Melanoma surgery trial: could less be just as good?
NCT ID NCT07049276
Summary
This study is testing if a smaller surgery is as good as the standard, larger surgery for people with stage III melanoma that has spread to lymph nodes. After 6 weeks of immunotherapy, participants will be randomly assigned to have either just the main affected lymph node removed or all lymph nodes in the area removed. The main goal is to see if the smaller surgery leads to the same chance of staying cancer-free for 2 years, while also aiming to reduce side effects and improve quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA, STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai Medical Centre
NOT_YET_RECRUITINGLos Angeles, California, 90025, United States
Contact
-
Melanoma Institute Australia
RECRUITINGWollstonecraft, New South Wales, 2065, Australia
Contact
-
North Shore Hospital
NOT_YET_RECRUITINGTakapuna, Auklnad, New Zealand
Contact
-
San Maria della Misericordia Hospital
NOT_YET_RECRUITINGPerugia, Italy
Contact
-
Sunnybrook Health Sciences Centre
NOT_YET_RECRUITINGToronto, Ontario, Canada
Contact
-
The Royal Marsden
NOT_YET_RECRUITINGLondon, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.